PURETECH HEALTH PLC

PRTC
Real-time Estimate Quote. Real-time Estimate  - 08/11 04:34:59 am
227GBX +0.89%
Valuation
Fiscal Period: December 2021 2022
Capitalization1 1 137784
Enterprise Value (EV)2 723415
P/E ratio -18,8x-5,41x
Yield --
Capitalization / Revenue 65,4x65,9x
EV / Revenue 41,6x34,8x
EV / EBITDA -5,06x-2,56x
Price to Book --
Nbr of stocks (in thousands) 287 797284 356
Reference price (USD) 3,952,76
Announcement Date 04/26/2022-
Previous period Next period
1 GBP in Million
2 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2021 2022
Net sales1 17,411,9
EBITDA1 -143-162
Operating profit (EBIT)1 -150-175
Operating Margin -864%-1 471%
Pre-Tax Profit (EBT)1 -59,0-159
Net income1 -60,6-158
Net margin -348%-1 331%
EPS2 -0,21-0,51
Dividend per Share2 --
Announcement Date 04/26/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2021 2022
Net Debt1 --
Net Cash position1 414370
Leverage (Debt / EBITDA) 2,89x2,28x
Free Cash Flow --
ROE (Net Profit / Equities) --
Shareholders' equity1 --
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share2 -0,55-0,59
Capex1 -6,00
Capex / Sales -50,4%
Announcement Date 04/26/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Financial Ratios
Size 2022e 2023e
Capitalization 784 M $ -
Enterprise Value (EV) 415 M $ 575 M $
Valuation 2022e 2023e
P/E ratio (Price / EPS) -5,41x -5,34x
Capitalization / Revenue 65,9x 50,0x
EV / Revenue 34,8x 26,4x
EV / EBITDA -2,56x -2,42x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) -1 471% -1 260%
Operating Leverage (Delta EBIT / Delta Sales) -0,52x -
Net Margin (Net Profit / Revenue) -1 331% -1 132%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   50,4% 41,4%
Cash Flow / CA -1 421% -1 105%
Capital Intensity (Assets / Revenue) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend